Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Three-dimensional conformal radiation therapy for non-small-cell lung cancer: A Phase I/II dose escalation clinical trial

By Wu K.-L.   Jiang G.-L.   Liao Y.   Qian H.   Wang L.-J.   Fu X.-L.   Zhao S.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1336-1344

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

By Goh Boon C.   Lehnert Manfred   Lim Hong L.   Ng Alan W. K.   Chan Choong C.   Kong Hwai L.   Lee Soo C.   Wee Joseph   Chua E. T.   Wong John E. L.  

Acta Oncologica, Vol. 39, Iss. 2, 2000-08 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

By Fujii Masato   Tsukuda Mamoru   Satake Bunsuke   Kubota Akira   Kida Akinori   Kohno Naoyuki   Okami Kenji   Inuyama Yukio  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 107-112

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite